AR / PCC herb pair inhibits osteoblast pyroptosis to alleviate diabetes‐related osteoporosis by activating Nrf2/Keap1 pathway
Journal of Cellular and Molecular Medicine · 2023-11 · 27 (22) · 3601-3613
DOI: 10.1111/jcmm.17928 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 24.08.2023. Verfasst von Fangda Fu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Orthopaedics and Traumatology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Tra…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Anemarrhena, Osteoporosis. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Chinese Medical University Schoo-level Education and Teaching Reform Project, National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Osteoporosis is a prevalent complication of diabetes, characterized by systemic metabolic impairment of bone mass and microarchitecture, particularly in the spine. Anemarrhenae Rhizoma/Phellodendri Chinensis Cortex (AR/PCC) herb pair has been extensively employed in Traditional Chinese Medicine to manage diabetes; however, its potential to ameliorate diabetic osteoporosis (DOP) has remained obscure. Herein, we explored the protective efficacy of AR/PCC herb pair against DOP using a streptozotocin (STZ)‐induced rat diabetic model. Our data showed that AR/PCC could effectively reduce the elevated fasting blood glucose and reverse the osteoporotic phenotype of diabetic rats, resulting in significant improvements in vertebral trabecular area percentage, trabecular thickness and trabecular number, while reducing trabecular separation. Specifically, AR/PCC herb pair improved impaired osteogenesis, nerve ingrowth and angiogenesis. More importantly, it could mitigate the aberrant activation of osteoblast pyroptosis in the vertebral bodies of diabetic rats by reducing increased expressions of Nlrp3, Asc, Caspase1, Gsdmd and IL‐1β. Mechanistically, AR/PCC activated antioxidant pathway through the upregulation of the antioxidant response protein Nrf2, while concurrently decreasing its negative feedback regulator Keap1. Collectively, our in vivo findings demonstrate that AR/PCC can inhibit osteoblast pyroptosis and alleviate STZ‐induced rat DOP, suggesting its potential as a therapeutic agent for mitigating DOP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Orthopaedics and Traumatology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China.
- Department of Pharmacy, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
- The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
- The Fourth Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China.
- Department of Orthopaedics, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
- Department of Architecture, School of Architecture, China Academy of Art, Hangzhou, China.
ORCID-Profile: Hongfeng Ruan
Förderung
- Zhejiang Chinese Medical University Schoo-level Education and Teaching Reform Project
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
- Research Project of Zhejiang Chinese Medical University
- Traditional Chinese Medical Administration of Zhejiang Province
- Research Project of Zhejiang Chinese Medical University Affiliated Hospital
- Zhejiang Medical and Health Science and Technology Project
Zitieren
APA
Fu, F., Luo, H., Du, Y., Chen, Y., Tian, K., Pan, J., Li, J., Wang, N., Bao, R., Jin, H., Tong, P., Ruan, H., & Wu, C. (2023). AR / PCC herb pair inhibits osteoblast pyroptosis to alleviate diabetes‐related osteoporosis by activating Nrf2/Keap1 pathway. Journal of Cellular and Molecular Medicine, 27(22), 3601-3613. https://doi.org/10.1111/jcmm.17928
Vancouver
Fu F, Luo H, Du Y, Chen Y, Tian K, Pan J, et al. AR / PCC herb pair inhibits osteoblast pyroptosis to alleviate diabetes‐related osteoporosis by activating Nrf2/Keap1 pathway. Journal of Cellular and Molecular Medicine. 2023;27(22):3601-3613. doi:10.1111/jcmm.17928
BibTeX
@article{Fu2023,
author = {Fu, Fangda and Luo, Huan and Du, Yu and Chen, Yuying and Tian, Kun and Pan, Jin and Li, Jian and Wang, Nani and Bao, Ronghua and Jin, Hongting and Tong, Peijian and Ruan, Hongfeng and Wu, Chengliang},
title = {AR / PCC herb pair inhibits osteoblast pyroptosis to alleviate diabetes‐related osteoporosis by activating Nrf2/Keap1 pathway},
journal = {Journal of Cellular and Molecular Medicine},
year = {2023},
volume = {27},
number = {22},
pages = {3601--3613},
doi = {10.1111/jcmm.17928}
}
EUVIMED